QualityStocksNewsBreaks Archives - Page 308 of 1503

MondaySep 25, 2023 12:47 pm

QualityStocksNewsBreaks – Astra Energy Inc. (ASRE) Announces Strategic Agreement with Holcomb Energy Systems, Board Appointment of Dr. Robert Holcomb

Astra Energy (OTCQB: ASRE) today announced an agreement with Holcomb Energy Systems LLC (“HES”), which secures exclusive worldwide manufacturing rights to the HES In-Line Power Generator (“ILPG”) and the HES Self-Sustaining Power Plant, two exceptional technologies that are poised to revolutionize the energy sector. According to the announcement, the agreement secures the right for Astra to manufacture both products in-house, as well as to sub-license manufacturing rights to qualified joint venture partners. Both HES technologies, which use no fuel, have no moving parts and produce zero emissions, are scalable and hold an exceptionally wide range of applications within the global…

MondaySep 25, 2023 12:26 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives EPA Certification for Class 3 EV Commercial Vehicles

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its achievement of a key milestone with full approval from the Environmental Protection Agency (“EPA”) with certification for Class 3 EV Commercial Vehicles received on Sept. 22, 2023. According to the announcement, Class 3 vehicle production began in August 2023 with the first vehicles rolling off the assembly line on Aug. 21, 2023. In addition, the Mullen Class 3 EV Cab Chassis Truck has completed all required testing requirements for Federal Motor Vehicle Safety Standards (“FMVSS”) and compliance. “I am extremely proud of this important milestone and, now…

MondaySep 25, 2023 10:53 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Releases Significant Long-Term Survival Improvement Data from ALS Trial

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc. are reporting on long-term follow-up data for participants in the HEALEY ALS Platform Trial; patients in the study were treated with CNM-Au8(R) 30mg for up to 133 weeks. According to the announcement, data from 59 patients shows prolonged life with 49% decreased risk of death for participants compared to PRO-ACT matched placebo over long-term follow-up; data also showed prolonged life with 59% decreased risk of death for participants in an integrated meta-analysis across HEALEY ALS Platform Trial and RESCUE-ALS Trial with CNM-Au8 30mg compared to PRO-ACT matched placebo over long-term follow-up.…

MondaySep 25, 2023 10:09 am

QualityStocksNewsBreaks – Near Intelligence Inc. (NASDAQ: NIR) Announces Seasoned Industry Veterans as New Board Members

Near Intelligence (NASDAQ: NIR), a data intelligence platform that curates one of the world’s largest sources of intelligence on people and places, has appointed two new members to its board of directors. According to the announcement, Richard J. Salute, a former director of Capital Markets and SEC Practice at J.H. Cohn and CohnReznick LLP, and Sherman Edmiston III, a managing member of HI CapM Advisors Ltd., have joined Near Intelligence’s board of directors, effective Sept. 19, 2023; a CPA, Salute will also serve as chair of the board audit committee. With more than 39 years of audit, accounting and tax experience,…

MondaySep 25, 2023 9:14 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 Security Robot Deployed in NYPD Pilot Program

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that the city of New York and the New York Police Department (“NYPD”) launched the Knightscope K5 security robot service. The move was announced at a press conference with the support of the Metropolitan Transportation Authority (“MTA”). The first two weeks will be spent on training, configuration and setup protocols for the autonomous robot to navigate followed by patrol activities between the hours of 12:00 a.m. and 6:00 a.m. at the Times Square Subway Station. “Today we are launching a pilot program…

FridaySep 22, 2023 3:45 pm

QualityStocksNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Aspiring to Change the Face of the Oil and Gas Industry

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation and development company focused on Western Canada, appears poised for record growth. This builds on “the success from 2022, when the company realized a net income of $3.1 million and experienced rapid growth when its revenue grew by a staggering 860% in Q2 2022. Prospera Energy expects significant reductions in production costs through 2024 and sizable increases in daily production. The company is currently exploring strategic acquisition targets to diversify Prospera heavy/light/gas product mix and path to 5,000 BPD over the next 24 months while expanding…

FridaySep 22, 2023 2:34 pm

QualityStocksNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Making Significant Strides to Advance Cellular Therapy Programs

Longeveron (NASDAQ: LGVN) is a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty. “The company is guided by the mission to advance cell-based product candidates into pivotal phase 3 trials, with the goal of attaining regulatory approvals and subsequently commercializing the product. Longeveron has so far made significant strides in line with this mission,” reads a recent article that discussed attendance by the company’s CEO Wa’el Hashad and EVP and CFO Lisa Locklear at the recent 25th Annual H.C. Wainwright Global Investment Conference. At the…

FridaySep 22, 2023 1:57 pm

QualityStocksNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)

RVL Pharmaceuticals (NASDAQ: RVLP) is a a specialty pharmaceutical company whose near-term focus is to continue the rollout of UPNEEQ(R) into the medical aesthetics market through its dedicated sales force. “UPNEEQ(R) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis… UPNEEQ(R), the first and only FDA-approved eye drop for low-lying eyelids, fits into the non-invasive medical aesthetics category. With a single drop per day, clinical trials showed an average of one-millimeter lift to the upper eyelid, improving appearance and the superior visual field in patients with a functional deficit. Testing also…

FridaySep 22, 2023 1:46 pm

QualityStocksNewsBreaks – SOHM Inc. (SHMN) Expands Team to Direct Global Growth Strategy

SOHM (OTC: SHMN) is a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories. “SOHM is strengthening its governing team with the addition of two experienced visionaries committed to helping the company’s growth in the pharmaceutical, nutraceutical and cosmeceutical marketplace… The new officers are expected to help direct SOHM’s global growth strategy as the company continues to develop and diversify its product offerings, which include a variety of mediums for administering antibiotics, analgesics, anti-inflammatory and anti-cold therapies, as well as vitamins,” a recent article reads. “Dr. Krishna Bhat, MD, Ph.D, FACC, an experienced bioscientist…

FridaySep 22, 2023 1:38 pm

QualityStocksNewsBreaks – Why PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’

PaxMedica (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions with intractable neurologic symptoms. “The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself. PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions,” a recent article reads. “PaxMedica’s lead programs, PAX-101 and PAX-102, utilize…

Site Search

Company Search

Category: QualityStocksNewsBreaks